“Personalized Immunotherapy for Treatment of Rare Diseases”

03 July 2024 | 16-17 CEST | Webinar

Over 30 million EU citizens suffer from 6,000+ rare diseases, 80% of which are genetic and often life-threatening with no approved treatments. Personalized immunotherapy, targeting unique genetic profiles, offers hope.

In this webinar, you will learn about:

• Specifics and challenges of drug development in Advanced Therapy Medicinal Products (ATMP)
• The potential of personalized immunotherapy for rare diseases

Regina Demlová, Ph.D., Assoc. Prof., specializes in clinical pharmacology and trial design. Since 2011 she has been the head of the Institute of Pharmacology at Masaryk University and is also the principal investigator of the CZECRIN project. Since 2024 she has been leading the CREATIC Centre of Excellence at Masaryk University, which focuses on cutting-edge research and development of cell and gene therapy.

SPARK Poland invites you to join our webinar on  July 3rd at 16:00 CET. Online via MS Teams. Please register here

Please note that you will receive the meeting link and access code the evening before the lecture and that access to last minute registrations, cannot be guaranteed.